Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biotech investing
Biotech
Taxes, tariffs, interest rates hold key to biotech's future: EY
“This is probably one of the toughest years to predict,” Arda Ural, Ph.D., EY Americas Life Sciences Sector Leader, said on last week.
Kevin Dunleavy
Jun 18, 2025 9:50am
Fierce Biotech Fundraising Tracker: Antares, Mosanna & more
Jun 18, 2025 9:00am
Vivo Capital secures $740M to invest in biotechs
May 7, 2025 4:59pm
Deerfield unveils $600M healthcare fund
May 5, 2025 10:26am
Novo Holdings dials back investment as Trump stumps forecasters
Apr 28, 2025 10:33am
Why biotechs can benefit from the 'rational' IPO environment
Jan 24, 2025 10:30am
